Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1063816

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to encourage more people into nursing.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	222751
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>There are more than 16,000 more nurses on our wards since May 2010. The Department of Health and Social Care has put in place significant actions to boost the supply of nurses, ranging from training more nurses, offering new routes into the profession, enhancing reward and pay packages to make nursing more attractive and improve retention, and encouraging those that have left to return to nursing. In 2018 NHS England and Health Education England ran an extensive communication campaign ‘we are the NHS’ which was focused on highlighting the positive image of nursing as a career.</p><p>The Department has made available funding for up to 5,000 additional clinical placements for nursing degrees in England.</p><p>Apprenticeships play a key role in ensuring the National Health Service has a future workforce, and the Department is committed to broadening routes into nursing. For the first time we now have a complete pathway of apprentice standards into nursing, from entry level Healthcare Support Worker, to Nursing Associate and onto the Nurse Degree Apprenticeship and Advanced Clinical Practice.</p><p>The latest data from the University and College Admissions Service (UCAS) shows that there has been a 4.5% increase in applicants to nursing or midwifery courses at English universities when compared to this time last year, 2018<sup>1</sup>.</p><p>The NHS Long Term Plan, published on 7 January 2019, sets out a vital strategic framework to ensure that over the next ten years the NHS will have the staff it needs. This will ensure that nurses are able to offer the expert compassionate care that they are committed providing.</p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding Chair of NHS Improvement, working closely with Sir David Behan Chair of Health Education England, to undertake a programme of work to develop a detailed workforce implementation plan. These programmes will consider proposals to grow the workforce, which will include growing the nursing workforce in order to ensure that the NHS has a sustainable supply of future nurses.</p><p> </p><p><sup>1</sup>Latest UCAS data received on 7 February 2019 shows that 34,030 people from all domiciles have applied to study nursing and midwifery courses at English universities as at 15 January 2019.</p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/02/2019 13:09:38 answering member 1585 label Biography information for Stephen Hammond
tabling member	1436 label Biography information for Paul Farrelly

1062107

registered interest
date	15/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Royal Liverpool and Broadgreen University Hospitals NHS Trust: Public Appointments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to appoint a new Chief Executive Officer of the Royal Liverpool and Broadgreen University Hospitals NHS Trust; and if he will make a statement.
tabling member constituency	Liverpool, Riverside
tabling member printed	Dame Louise Ellman
uin	222002
answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>Executive appointments are made by a committee of the Board of the NHS Trust in accordance with Schedule 4 to the NHS Act 2006 and the National Health Service Trusts (Membership and Procedure) Regulations 1990. The committee consists of the chair, the non-executive directors and, in the case of an appointment other than the chief executive, the chief executive.</p><p> </p><p>Aintree University Hospitals NHS Foundation Trust has proposed an acquisition of the Royal Liverpool and Broadgreen University Hospitals NHS Trust, which is planned to take place on 1 October 2019. The chief executive of The Royal Liverpool and Broadgreen University Hospitals NHS Trust is due to leave the post at the end of March 2019 and the Trust is currently undertaking a recruitment process for an interim chief executive for a period of six months from 1 April 2019 to 30 September 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/02/2019 13:50:02 answering member 1585 label Biography information for Stephen Hammond
tabling member	484 label Biography information for Dame Louise Ellman

1060959

registered interest
date	14/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Hampshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to deliver a new critical treatment hospital for north Hampshire.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	909301
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>A joint meeting of the governing bodies of the North and West Hampshire Clinical Commissioning Groups decided in November 2017 not to take forward a proposal for a new critical treatment hospital for north Hampshire, following a detailed review of options. The local health economy is now working in partnership to consider other future service configuration options through their Transforming Care Services Board, informed by the view of local patients and the public.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 19/02/2019 11:37:40 answering member 1585 label Biography information for Stephen Hammond
tabling member	4498 label Biography information for Mr Ranil Jayawardena

1060592

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many weeks’ worth of medicines the Government has asked pharmaceutical companies to stockpile as part of preparations for the UK leaving the EU without a deal; and how his Department decided on that period of duration.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	220998
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 221000 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060594

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information he holds on those NHS breast cancer drugs that pharmaceutical companies will have six weeks' supply of by 29 March 2019.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	221000
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220998 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060618

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Brexit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the cost to the public purse of his Department's preparations for the UK leaving the EU without a deal.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	220768
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Of the £71.1 million funding the Department has been allocated for 2018/19 and 2019/20 for preparations for European Union exit, we are unable to provide a breakdown of the amount of funding allocated to ‘no deal’ preparations specifically, as this cannot be separated from EU exit work as a whole across the Department.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:21:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	308 label Biography information for Mr Jim Cunningham

1060620

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, what advice he has for people on kidney dialysis who wish to travel in the EU or EEA and to whom his advice of 28 January 2019 does not cover because dialysis is not covered under travel insurance.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220902
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220903 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060621

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, when he will issue an update to that advice for people on kidney dialysis who wish to travel to the EU or EEA.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220903
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060622

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what advice he has on compensation to people on dialysis who book, or who have already booked, travel to the EU or EEA and who have to cancel it because they are unable to secure State-funded dialysis treatment whilst they are away.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220904
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220903 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060643

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	220816
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.</p><p> </p><p>The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom’s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.</p><p> </p><p>As a responsible Government, we are planning for all possible exit scenarios, including ‘no deal’. Our ‘no deal’ medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.</p><p> </p><p>On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a ‘no deal’ EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.</p><p> </p><p>We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:10:21 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan